I had already made 2 appln but haven't added any more. Will wait for 2.45 to see if any more can be added. Anyways i am not going to withdraw the previous 2 as sub fig can be considered as decent.
QIBs 1.92X NII 0.10X RIIs 1.30X Emp 0.02X Total 1.26X
86. PSR| Link| Bookmark|
April 5, 2019 1:44:02 PM
IPO Guru (1200+ Posts, 700+ Likes)
Total Subscription ------------- 117%
85. PSR| Link| Bookmark|
April 5, 2019 1:43:06 PM
IPO Guru (1200+ Posts, 700+ Likes)
Total Subscription --------- 117%
84. A.K. Goyal| Link| Bookmark|
April 5, 2019 10:23:20 AM
Top Contributor (200+ Posts, 100+ Likes)
Hi , i m facing problem in applying for ipo through HDFC bank.it is saying " server could not process your request, try latter ", since last 2 days. Is someone else facing same problem
Somebody help me. I applied through HDFC netbanking asba ipo application on april 3. Now i tried to cancel application. I selected from order book clicked cancel bid. A menu opened with BID and a check box but i did not check the box and clicked cancel full application instead of cancel selected bids as i did not select any. Then it said bid(s) cancellation successful for my application number. I checked order book again it shows ipo status under process and order ID modified but paid amount and application amount shows as 0. Funds are still on hold and can not be released. Is the application cancelled or not ? and when will the funds be released ? Or did the application not cancelled because i did not check any bids and selected cancel full application ? Please help
Thank you. So it is ok if i have not selected the check box against bid in HDFC netbanking asba ?
I also wanted to cancel one application in canara asba but it is not giving me option to delete bid ? And they are not able to help. How can i cancel this bid ? or should i make another application so that both get cancelled ? Can i apply once again through canara bank to generate another application ? Or apply through a third party ?to get it done ?
This is a pattern now since march rally , retail is subscribing heavily on all IPO s and HNI and QIB are holding back. Any reason for this peculiar pattern?? Even here in Metropolis RII is fully subscribed and others quotas are struggling to be subscribed
COMPETITOR DR LALPATH LAB,FACE VALUE IS RS 10 & ITS TODAY PRICE IS RS 1030/- AGAINST METROPOLIS FACE VALUE RS 2 & SHARE PRICE RS 880/- SO METROPOLIS SHARE VALUE FOR FACE VALUE FOR RS 10 WILL BE 4400 RS.IT IS TOO COSTLY
78.1. papon| Link| Bookmark|
April 5, 2019 11:58:55 AM
IPO Mentor (500+ Posts, 500+ Likes)
No point looking at face value. Look at eps & pe. If you convert face value to 10 from 2 than you have to multiply eps with 5 times. Than you will find that eps is lot more compared to dr lal
@ 880 . Valuations are same as of Dr. Lal Path Lab.So listing could hover around 880-900.On upper side hardly 10-20 Rs. Listing Gain possible.From secondary market it will be available below 800.Better to skip this IPO and apply in Polycab with full force.Muthoot , Narmada Bio , Harsh Eng. and some other IPOs are coming shortly.Wait for the good IPOs.
It is highly overpriced IPO. Money collected through this IPO will not be used by company which is another big negative. Sector is also highly competitive. Hence a clear avoid
Why does Govt circulars don't provide full clarity on notices. There is no clarification whether an investor can use his own other bank account to apply IPO which is not linked to demat account? For example, I have kotak bank linked to my demat, so can I apply from my hdfc bank account? So much confusion. Does anyone has any idea.
If you apply for accont which are not linked to your Demat then RTA will unable to validate account number and application are liable for Rejection. So always apply Demat linked account
I am applying from my sbi account for my parents quite frequently. And being alloted as well. My parents have account only in icici which is linked to their demat account.
Metropolis IPO View: Metropolis Healthcare is currently a debt free company. It reported a return on capital of 30 percent, return on capital employed at 44 percent and return on net worth of 25 percent in the financial year ended March 2018 The company's revenue grew at an annualised rate of 16 percent over financial years 2016 to 2018. Its operating and net profit grew at 17 percent and 16 percent, respectively, during the period.
Metropolis Healthcare will be India's second-largest diagnostic centre by revenue among listed peers. Fortis Healthcare Ltd.-owned SRL Diagnostic is not separately listed. While Metropolis Healthcare trades at a discount of 16 percent to Dr Lal PathLabs by 2018-19 price-to-earnings ratio, it's at a 22 percent premium to Thyrocare Technologies. Based on the healthcare segment especially in the case of Diagnostic chain long term outlook is good. Long term horizon investor can apply.
Simple words : Expensive. Stay away, if you are a low risk or short term speculator. Fit for long term, provided, you are fine with little overpriced issue. Compulsive IPO gainseekers may try their luck, given the positive outlook for general markets.
True, We can't say anything on subscription figures before 1.45 pm tomorrow. Actually real picture will be clear by 4 pm tomorrow, but lets hope we can get close picture at 1.45.